Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × repotrectinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Thyroid Neoplasms 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Sarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Carcinoma, Neuroendocrine 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Bronchial Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 21 Radiotherapy 14 Erlotinib Hydrochloride 13 Magnetic Resonance Spectroscopy 12 Carboplatin 10 Bevacizumab 10 Pemetrexed 9 pembrolizumab 8 Gefitinib 8 osimertinib 7 icotinib 7 Temozolomide 6 Nivolumab 6 Paclitaxel 5 Spermine Synthase 4 Specimen Handling 4 Ipilimumab 4 atezolizumab 3 aflutinib 3 Mental Status and Dementia Tests 3 Fluorodeoxyglucose F18 3 Drug Therapy 3 regorafenib 2 paclitaxel-Angiopep-2 conjugate 2 motexafin gadolinium 2 epothilone B 2 cemiplimab 2 cediranib 2 cabazitaxel 2 aumolertinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06315010 2026-02-25

REPOSE

MedSIR

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡